Nature5 年
Use of PPIs not associated with osteoporosis or loss of bone mineral density
“PPI use does not appear to be associated with osteoporosis or accelerated [bone mineral density (BMD)] loss,” according to Laura Targownik and colleagues from the University of ...
Medscape13 天
Use of proton pump inhibitors and risk of osteoporosis-related fractures.
We sought to further explore the relation between duration of exposure to proton pump inhibitors and osteoporosis-related fractures. METHODS: We used administrative claims data to identify ...
Medscape9 天
Drug-induced Osteoporosis in the Older Adult
No data exist to prevent PPI and H 2 RA effects on calcium ... II diabetes in women that are at high risk for osteoporosis and fractures. Mechanism of Action The proposed mechanism by which ...
Nature5 年
PTHrP modifies the efficacy of administered PTH 1–34: implications for osteoporosis treatment
Most therapies for osteoporosis slow the resorption of bone ... to explore the molecular mechanisms that mediate the anabolic effects of PTH and why individuals vary in their response to it.